- Home
- MESA vs BOLD Comparison
MESA vs BOLD Comparison
Compare MESA & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- BOLD
- Stock Information
- Founded
- MESA 1982
- BOLD 2018
- Country
- MESA United States
- BOLD United States
- Employees
- MESA N/A
- BOLD N/A
- Industry
- MESA Air Freight/Delivery Services
- BOLD
- Sector
- MESA Consumer Discretionary
- BOLD
- Exchange
- MESA Nasdaq
- BOLD Nasdaq
- Market Cap
- MESA 46.7M
- BOLD 59.8M
- IPO Year
- MESA 2018
- BOLD 2024
- Fundamental
- Price
- MESA $1.26
- BOLD $2.68
- Analyst Decision
- MESA
- BOLD Buy
- Analyst Count
- MESA 0
- BOLD 3
- Target Price
- MESA N/A
- BOLD $22.50
- AVG Volume (30 Days)
- MESA 255.0K
- BOLD 134.8K
- Earning Date
- MESA 01-14-2025
- BOLD 11-07-2024
- Dividend Yield
- MESA N/A
- BOLD N/A
- EPS Growth
- MESA N/A
- BOLD N/A
- EPS
- MESA N/A
- BOLD N/A
- Revenue
- MESA $475,518,000.00
- BOLD N/A
- Revenue This Year
- MESA $15.09
- BOLD N/A
- Revenue Next Year
- MESA $16.19
- BOLD N/A
- P/E Ratio
- MESA N/A
- BOLD N/A
- Revenue Growth
- MESA N/A
- BOLD N/A
- 52 Week Low
- MESA $0.55
- BOLD $2.33
- 52 Week High
- MESA $1.89
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- MESA 59.98
- BOLD N/A
- Support Level
- MESA $1.16
- BOLD N/A
- Resistance Level
- MESA $1.37
- BOLD N/A
- Average True Range (ATR)
- MESA 0.11
- BOLD 0.00
- MACD
- MESA 0.01
- BOLD 0.00
- Stochastic Oscillator
- MESA 66.67
- BOLD 0.00
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.